Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Rating) – Cantor Fitzgerald issued their FY2023 earnings per share (EPS) estimates for Lyra Therapeutics in a note issued to investors on Monday, June 6th. Cantor Fitzgerald analyst L. Chen forecasts that the company will post earnings of ($1.68) per share for the year. Cantor Fitzgerald has a “Overweight” […]